The proteasomal inhibition model of Parkinson's disease: "Boon or bust"?
Beal
Flint
F
Lang
Anthony
A
D000818:Animals; D015853:Cysteine Proteinase Inhibitors / Q000633:toxicity*; D004195:Disease Models, Animal; D006801:Humans; D009842:Oligopeptides / Q000633:toxicity*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000473:pathology; D011323:Primates; D051381:Rats; D011916:Rats, Inbred F344; D017207:Rats, Sprague-Dawley; D015203:Reproducibility of Results; D013378:Substantia Nigra / Q000473:pathology
D015853:Cysteine Proteinase Inhibitors; D009842:Oligopeptides; C090535:benzyloxycarbonyl-isoleucyl-glutamyl(O-tert-butyl)-alanyl-leucinal